Browse Ageing Research Programmes

You are browsing data that matches the following criteria. Click the cross in any box to remove that search criteria.
Funder/CentreFederal Ministry of Education and Research
Programme:Benefits and risks of hormone replacement therapy
Hide ▴

Federal Ministry of Education and Research

Show all funders/centres
  • Research Programmes
  • Research Projects

Need some help?

If you find yourself getting a bit lost, try using one of the links below to get back to the beginning:

  • Go back to the start page
    You can search the whole database for specific search terms, choose a country or browse by category.
  • Perform an advanced search
    Useful when you know what you're looking for, and where the data might be stored.
  • Browse all Research Centres and Funders
    See a list of all centres from where you can view details and the programmes and projects that are associated with that centre/funder.
  • Browse all Research Programmes
    See a list of all the research programmes in the database. When you look at one you will automatically see which Research Funder/Centre it belongs too, and you can explore this programme's projects or see other programmes within the same funder/centre.
  • Browse all Researchers
    Individual researchers are not "attached" to any particular project or programme. If you want to narrow down the list you could choose a country on the start page and look at the list on the left of the page..
Benefits and risks of hormone replacement therapyResearch Programme

Website

http://www.gesundheitsforschung-bmbf.de/de/970.php

Programme type

Research programme

Programme status

Ongoing

Total number of funded projects

11

Summary of key aims

In view of the potential risks for women in the menopause by taking oestrogen compounds (hormone replacement therapy), the program intends to promote research approaches that are of practical relevance to the affected women and assist them and their doctors in weighing the benefits and risks of using hormone replacement therapy. The studies (clinical, epidemiological) should deal (i) with questions relevant to clinical practice/ general patient care concerning the benefits and risks of hormone therapy, (ii) dealing with questions concerning the assessment of benefits and risks by doctors and patients if the project results can be expected to benefit patients and to contribute to transparency and greater certainty or (iii) focus on the connection between certain diseases, e.g. cancer, and the use of hormone products, taking into consideration the long periods of use of such therapy in Germany.

Management contact

Dr. Siegle-Barth, Dr. Kälin
(+49) 0228 - 3821 25
PT-DLR
Heinrich-Konen-Straße 1
D-53227 Bonn

Admin contact

PT-DLR
(+49) 0228 - 3821 25
PT-DLR
Heinrich-Konen-Straße 1
D-53227 Bonn

Funding contact

Dr. Kälin
BMBF
Dienstsitz Bonn
Heinemannstr. 2
53175 Bonn

Is the project externally evaluated?

No

Who has evaluated, or will evaluate, the programme?

BMBF, PT-DLR

What forms of international collaboration does the programme support?

  • ▪ Travel for foreign collaborators
  • ▪ National researchers abroad
  • ▪ Travel for national researchers

Interdisciplinary research is a strategic priority...

  • For the programme ✔
  • For the funding agency ✔
  • Nationally ✔